New antibiotic effectively treats complicated UTIs, trial finds
By
Alicia Lasek
Oct 20, 2020
The new antibiotic cefiderocol (Fetroja) compared favorably with other standard therapies when treating patients with life-threatening drug-resistant infections.
Remdesivir effective against COVID-19, researchers conclude
By
Alicia Lasek
Oct 13, 2020
Intravenous remdesivir shortens recovery time and reduces mortality in hospitalized patients when compared to placebo, according to final trial data from NIAID. No other antiviral has yet been confirmed...
Seniors are absent — but necessary — in COVID-19 vaccine trials, experts say
By
Alicia Lasek
Sep 29, 2020
With older adults frequently excluded in COVID-19 clinical trials, investigators are concerned that they will ultimately be denied treatments and vaccines due to safety concerns.
COVID-19 vaccine hopefuls show early promise in clinical trials
By
Alicia Lasek
Jul 22, 2020
Positive results in two more vaccine trials add to a small but growing list of successes among COVID-19 treatment candidates. The results are encouraging, say vaccine experts.
Drug may hasten recovery in moderately ill COVID-19 patients
By
Alicia Lasek
Jun 01, 2020
The antiviral drug remdesivir has been shown to improve recovery time in moderate COVID-19 illness, drugmaker Gilead Sciences announced Monday.
ALS drug ‘significantly’ slows disease progression in late-stage trial
By
Alicia Lasek
Dec 17, 2019
Participants taking AMX0035 had slower ALS disease progression than those given a placebo, the drug’s developer reports.
New rheumatoid arthritis drug works ‘exceptionally’ well in clinical trials
By
Alicia Lasek
Jul 23, 2019
In clinical tests, a new drug has succeeded in alleviating rheumatoid arthritis symptoms in patients who had found no relief from traditional therapies.
Practice Fusion, ePatientFinder launch clinical trial recruitment
Apr 21, 2015
Practice Fusion, an EHR vendor, and ePatientFinder have announced a partnership they said would create nation’s largest clinical trial recruitment network.
An Alzheimer’s reality check
By
Tim Mullaney
Nov 12, 2013
Alzheimer’s researchers — or the public relations machines breathlessly trumpeting their work — should chill out. I see so much of this type of Alzheimer’s news that it’s hard to...
Drugs, the lottery and your company’s future
By
John O'Connor
Apr 09, 2012
Having recently plunked down a $120 co-pay for medicine that was a far cry from designer caliber, I can relate to people who believe drugs are too expensive.